Training program on new long-acting HIV injectable Cabotegravir for PrEP and Cabotegravir/Rilpivirine for treatment. Dr. Amy Colson will address efficacy, benefits and challenges of long-acting injectables, where and how to administer, dosing schedules, and comparisons to oral medication. Bring any questions you have about HIV injectables and join us on May 3rd!
Speaker:
Amy Colson, MD
Research Director
Community Research Initiative
Continuing Education:
Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Massachusetts Medical School Office of Continuing Medical Education and New England AIDS Education and Training Center. The UMMS-OCME is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement: The University of Massachusetts Medical School designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Nurses: Under the auspices of the New England AIDS Education & Training Center, this offering meets the requirements for a maximum of 1.2 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.
Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services.
Funding: This program is supported by the Health Resources and Services Administration of the U.S. Department of Health and Human Services under grant number U1OHA29294 (AIDS Education and Training Centers) awarded to the University of Massachusetts Medical School. This information of content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.
